Diagnostics & Imaging Week articles from July 2008

Diagnostics & Imaging Week archives from July 2008

FDA grants CLIA waiver for HemoCue Albumin 201 test.
July 3, 2008... HemoCue (Angelholm, Sweden), a point-of-care (POC) diagnostic test manufacturer and a subsidiary of Quest Diagnostics (Madison, New Jersey), reported that its HemoCue Albumin 201 system is the first quantitative POC test for screening,...

Georgia hopes branding will lead to a fertile bio-crescent.(New ventures)
July 3, 2008... In an effort to promote the Georgia life sciences sector, a coalition made up of counties and organizations is reporting the formation of a branding campaign for Georgia's Innovation Crescent. The state has dubbed the Athens-to-Atlanta life...

Definiens in medical imaging sector with 4-D image analysis.(International report)
July 3, 2008... Definiens (Munich, Germany/Morristown, New Jersey) has launched a multi-dimensional image analysis platform, called Definiens XD, capable of extracting previously unattainable levels of intelligence from digitized medical data. The company...

House subcommittee opens purse strings to hungry FDA.(Washington roundup)(Brief article)
July 3, 2008... Suddenly, it has become fashionable to give FDA more money. After more than a decade and a half of diminishing resources, FDA is now the target of financial largess by both the executive and legislative branches of government as the recent...

Vicor CEO reviews plan for commercialization of PD2i.
July 3, 2008... At a recent annual shareholders meeting, Vicor Technologies' (Boca Raton, Florida) president/CEO, David Fater, reviewed strategies and developments to commercialize the company's PD2i Cardiac Analyzer for risk stratification of patients for...

Cardiac Science joins Russell 3000.(med-tech news and notes)(Brief article)
July 3, 2008... Cardiac Science (Bothell, Washington) said that it has been selected to join the Russell 3000 Index. Selection to the Russell 3000 index means Cardiac Science is automatically included in the Russell 2000 Index, which measures the performance...

Sequenom prices its offering; Luminex raises public $74 million.(Financings roundup)
July 3, 2008... Sequenom (San Diego) reported the pricing of its previously disclosed public offering of 5.5 million shares of its common stock at a public offering price of $15.50 a share. All of the shares are being offered by the company. The...

Isis Pharmaceuticals (Carlsbad, California) reported that Abbott Laboratories (Abbott Park, Illinois) has invested an additional $20 million in Ibis Biosciences, an Isis subsidiary.(Financings roundup)
July 3, 2008... * Isis Pharmaceuticals (Carlsbad, California) reported that Abbott Laboratories (Abbott Park, Illinois) has invested an additional $20 million in Ibis Biosciences, an Isis subsidiary. The investment will allow Ibis to further develop the Ibis...

Signature Genomic Laboratories.(Financings roundup)(Brief article)
July 3, 2008... * Signature Genomic Laboratories (Spokane, Washington) reported that jVen Capital, a life sciences investment company with a focus in the areas of biotechnology, diagnostics and devices, has acquired an equity interest in the company. In...

RadNet to join Russell 3000 Index.(med-tech news and notes)(Brief article)
July 3, 2008... RadNet (Los Angeles) is set to join the broad-market Russell 3000 Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, according to a preliminary list of additions. Annual...

Positron, Disease Management to co-develop CAD product.(Agreements)
July 3, 2008... Positron (Houston) and Disease Management have agreed to co-develop a coronary artery disease prevention and reversal software program and total disease management solution. The product will include a heart disease pre-test risk calculator,...

Texas researcher awarded $1.5M for nanoparticle cancer research.(Grants/contracts)
July 3, 2008... A biomedical engineering assistant professor at the University of Texas (Austin) has been awarded a $1.5 million National Institutes of Health/National Cancer Institute grant to conduct nanoparticle cancer research. Grant recipient James...

Diagnostic Hybrids (Athens, Ohio) has received funding through the Biomedical Research Commercialization Program (BRCP; Columbus, Ohio) to develop more sensitive and affordable assays for the monitoring of patients infected with HIV and/or Hepatitis C Virus (HCV) and to produce vaccines against influenza virus.(Grants/contracts)
July 3, 2008... * Diagnostic Hybrids (Athens, Ohio) has received funding through the Biomedical Research Commercialization Program (BRCP; Columbus, Ohio) to develop more sensitive and affordable assays for the monitoring of patients infected with HIV and/or...

Luminetx (Memphis) reported that it has signed a three-year supplier contract with Novation (Irving, Texas), a group purchasing organization.(Grants/contracts)
July 3, 2008... * Luminetx (Memphis) reported that it has signed a three-year supplier contract with Novation (Irving, Texas), a group purchasing organization. Novation is the healthcare contracting services company of VHA, University Health System...

GE Healthcare.(Grants/contracts)
July 3, 2008... * GE Healthcare (Chalfont St. Giles, England) is working with medical leaders in the Olympic Movement to advance the use of medical imaging technologies to provide insight into athlete health, as well as benefits for the general public. The...

Siemens Healthcare opens new radiopharmacies.(med-tech news and notes)(Brief article)
July 3, 2008... Siemens Healthcare (Malvern, Pennsylvania) has opened two new radiopharmacies in Las Vegas and Pittsburgh. These two new facilities will produce imaging biomarkers that are a component of PET-CT tests used to diagnose cancer and cardiac and...

Swiss-U.S. group tops bidding for clinics.(International report)
July 3, 2008... Two years after selling the family biotechnology business Serono to the Germany-based Merck pharmaceuticals firm for almost 7 billion [euro] ($8.4 billion, 2006), the Swiss-Italian billionaire Ernesto Bertarelli has returned to medical...

Panel: more studies for contrast agents.(Washington roundup)(Brief article)
July 3, 2008... An advisory committee recently recommended that FDA require makers of contrast agents for echocardiography to conduct larger studies to evaluate health risks. FDA required that contrast agents made by GE Healthcare (Waukesha, Wisconsin)...

House passes Medicare spending bill.(Washington roundup)
July 3, 2008... Now that the proverbial 11th hour has arrived, Congress is busily scraping together a passel of bills designed to beat the August recess. In a June 24 vote, the House passed the Medicare Improvements for Patients and Providers Act of 2008...

GAO says MA plans very profitable.(Washington roundup)
July 3, 2008... Medicare Advantage (MA) plans have become very controversial due to perceptions that they needlessly inflate the nation's Medicare tab, and a June 25 report by the Government Accountability Office concluded that MA plans are spending a lower...

U.S. sales of molecular tests drive Tepnel's growth.(International report)(Financial report)(Brief article)
July 3, 2008... On the strength of a 45% growth for 2007 in its molecular diagnostics division, Tepnel Life Sciences (Manchester, UK/Stamford, Connecticut) reported strong profitability for 2007 and CEO Ben Matzilevich told D&IW the company is "very...

Marketing accord for breast cancer test.(International report)
July 3, 2008... Provista Life Sciences (PLS; Phoenix) reported reaching a strategic partnering agreement with International Health Technology (IHT) to release the company's BT Test into the UK and Ireland. The BT Test, a new blood test to aid healthcare...

ACR Image Metrix.(People In Places)(appointment of Brenda Young )(Brief article)
July 3, 2008... Brenda Young has been named to the staff of ACR Image Metrix (Philadelphia) as senior director of clinical operations. Young's background includes many years of experience at the American College of Radiology, with previous experience as a...

Avid Radiopharmaceuticals.(People in Places)
July 3, 2008... Richard Baron was named CFO of Avid Radiopharmaceuticals (Philadelphia). Baron most recently was the CFO of eResearchTechnology. Avid Radiopharmaceuticals specializes in the diagnosis and monitoring of brain disorders.

Covidien.(People in Places)
July 3, 2008... Liesl Cooper, PhD, has been named VP, healthcare economics, policy and reimbursement for Covidien (Mansfield, Massachusetts). She joins Covidien from Johnson & Johnson's Cordis unit, where she was VP-health economics & reimbursement. Covidien...

R&D.(People in Places)(Covidien)(Brief article)
July 3, 2008... Michael Giuliani, MD, was named VP of R&D for pharmaceutical products and imaging solutions for Covidien (St. Louis). Dr. Giuliani comes to Covidien from Xanodyne Pharmaceuticals, where he was chief medical officer and executive VP of product...

IBT Laboratories.(People in Places)
July 3, 2008... Maureen Loftus was named president/COO of IBT Laboratories (Lenexa, Kansas). Previously, she was president of the Bode Technology Group. IBT Laboratories is a clinical diagnostics and biomedical research laboratory specializing in immunology...

Neoprobe.(People in Places)
July 3, 2008... Carl Aschinger Jr., Owen Johnson, MD, and Fred Miller have been re-elected as directors of Neoprobe (Dublin, Ohio) for terms ending at the 2011 annual meeting. Neoprobe makes oncology and cardiovascular surgical and diagnostic products.

Medical Tactile.(People in Places)
July 3, 2008... Denis O'Connor was named CEO of Medical Tactile (MTI; Los Angeles). O'Connor has held senior management positions at Philips Medical Systems, Sony Medical Systems and Lockheed Martin Medical Systems. Medical Tactile makes pre-mammography...

mtm laboratories.(People in Places)
July 3, 2008... Bob Silverman was named CEO of mtm laboratories (Heidelberg, Germany). Silverman has been mtm's chief commercial officer and president of the company's U.S. subsidiary since mid-2005. mtm laboratories makes in vitro diagnostics for cervical...

John F. Kennedy Memorial Hospital.(People in Places)
July 3, 2008... Tenet Healthcare (Dallas) reported that Dan Bowers was named CEO of John F. Kennedy Memorial Hospital, a 145-bed acute-care regional medical center located in Indio, California, east of Palm Springs. Bowers has been with Tenet since 1997,...

Rosetta Genomics.(People in Places)
July 3, 2008... Tamir Kazaz, CFO of Rosetta Genomics (Jersey City, New Jersey) for the past 2-1/2 years, has resigned. He is expected to leave during the second half of 2008, and will support the company in its search and during the transition of his duties....

Arkray USA.(Product Briefs)(Brief article)
July 3, 2008... Arkray USA (Minneapolis) reported FDA clearance for the Glucocard 01 blood glucose monitoring system. The Glucocard requires no coding, displays results in 7 seconds, and requires a 0.3 microliter sample size. Glucocard 01 is AST approved and...

Caris Diagnostics.(Product Briefs)
July 3, 2008... Caris Diagnostics (Irving, Texas) said it is offering KRAS mutation analysis, designed to provide information on which colon cancer patients are most likely to respond to cetuximab (Erbitux), co-marketed by ImClone and Bristol-Myers Squibb, or...

Compugen.(PRODUCT BRIEFS)(Brief article)
July 3, 2008... Compugen (Tel Aviv, Israel) reported the discovery and experimental confirmation of a combination of four biomarkers for early detection of drug-induced nephrotoxicity. Data demonstrate that the biomarker signature may enable a much earlier...

FDA clears first colorectal monitoring test since 1982.
July 10, 2008... AMDL (Tustin, California), a biopharmaceutical company with operations in China and the U.S., said the FDA has issued a letter of substantial equivalence to an existing predicate device and granted clearance to market the AMDL-ELISA DR-70 (FDP)...

Hybrid MRI gives microcellular look at 'remodeling' in lung.(While raising new questions about asthma ...)
July 10, 2008... Of all the diagnostic assessments that remain vague--offering a large variety of grey areas of interpretation (read, guesses), and frequently being flat-out wrong--the precise understanding of breathing problems is among the most difficult. ...

New sensors waking up sleep disorder markets in Europe.(International report)(PulseOx 7500 from SPO Medical Inc.)
July 10, 2008... Two companies are waking up European markets for sleep disorders as they explore the potential of at-home monitoring devices that detect sleep disturbances. SPO Medical (Simi Valley, California) said its has upgraded to its PulseOx 7500, a...

Invitrogen's Herceptin test PMA provides it new market direction.
July 10, 2008... Oncologist now have another weapon to add to their breast cancer armamentarium with the addition of a test that can help to determine if a patient is likely to respond well to Herceptin, a drug developed by Genentech (South San Francisco) and...

VCs, others say nonexistent IPO market worst in 30 years.
July 10, 2008... Some are calling it the possible demise of initial public offerings a "venture-backed IPO investment crisis." Others are saying the lack of IPOs in the most recently completed quarter is only natural and just another symptom of the country's...

CMS publishes 2009 payment proposal for ASCs, hospitals.
July 10, 2008... The Centers for Medicare & Medicaid Services continues its transformation of how it pays ambulatory surgical centers (ASCs) and hospitals for outpatient services, but each iteration of the four-year project nonetheless manages to raise a fresh...

St. Jude Medical to pay out $92.1m to EP Medsystems for common stock.(Deals roundup)
July 10, 2008... A Diagnostics & Imaging Week Staff Report St. Jude Medical (St. Paul, Minnesota) reported that in connection with the previously disclosed acquisition of EP MedSystems (West Berlin, New Jersey), the final exchange ratio is 0.0738 (rounded)...

Biomagnetics Diagnostics.(Deals roundup)(Biomagnetics Diagnostics has contracted with Southbridge Business Resources )(Brief article)
July 10, 2008... In other dealmaking news, Biomagnetics Diagnostics (Orangevale, California) reported launch of the process to acquire other businesses. It said it has secured acquisition capital and has contracted with Southbridge Business Resources...

Biospectrum Technologies .(Deals roundup)
July 10, 2008... Biomagnetics, through its subsidiary, Biospectrum Technologies (Orangevale), has patented diagnostic equipment and assays designed to be qualitative, quantitative and easily performed.

AMIC, MU deal to produce isotopes without nuclear reactor.(Agreements)
July 10, 2008... A Diagnostics & Imaging Week Staff Report Advanced Medical Isotope (AMIC; Kennewick, Washington) reported it has entered into an agreement for the development of a compact device to produce radioisotopes with the University of Missouri (MU;...

Sequenom to sell 825,000 shares for nearly $92 million.(Financings roundup)
July 10, 2008... A Diagnostics & Imaging Week Staff Report Sequenom (San Diego) reported that the underwriters of its previously announced common stock offering that priced on June 25 have exercised in full an option to purchase an additional 825,000 shares...

NightHawk Radiology Holdings.(Financings roundup)(NightHawk Radiology Holdings repurchases share of its common stock)(Brief article)
July 10, 2008... In other financing news, NightHawk Radiology Holdings (Coeur D'Alene, Idaho), a provider of radiology solutions to radiology groups and hospitals throughout the U.S., said its board has authorized up to $10 million of share repurchases of its...

Antigen awarded $3m SBIR grant for serodiagnostics.(Grants/contracts)
July 10, 2008... A Diagnostics & Imaging Week Staff Report Antigen Discovery (ADI; Irvine, California) reported receipt of a Phase II SBIR grant from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Center for Research...

Aetna (Atlanta) reported that it has awarded a $40,000 grant to the Ryan Cameron Foundation (Atlanta) to help fund a diabetes screening day, for which Aetna will be the title sponsor this fall.(Grants/contracts)
July 10, 2008... Aetna (Atlanta) reported that it has awarded a $40,000 grant to the Ryan Cameron Foundation (Atlanta) to help fund a diabetes screening day, for which Aetna will be the title sponsor this fall. Aetna representatives will share information...

CompuMed.(Grants/contracts)(CompuMed Inc. reported agreements with Prison Health Services Inc.)(Brief article)
July 10, 2008... CompuMed (Los Angeles) reported agreements to continue providing ECG remote interpretation systems and services for state correctional departments in Iowa and Wyoming. Under the terms of the Iowa Department of Corrections agreement,...

nSpire Health (Louisville, Colorado) said it signed a three-year contract with Premier Group Purchasing (San Diego).(Grants/contracts)
July 10, 2008... nSpire Health (Louisville, Colorado) said it signed a three-year contract with Premier Group Purchasing (San Diego). The dual-source agreement offers Premier hospitals and clinics access to nSpire Health's broad range of respiratory products...

Affymetrix, Asuragen to develop IVT reagent kits for diagnostics.(New ventures)
July 10, 2008... A Diagnostics & Imaging Week Staff Report Affymetrix (Santa Clara, California) and Asuragen (Austin, Texas), a molecular biology diagnostic company and service provider, have agreed to develop in vitro transcription (IVT) reagent kits for...

Aureon Laboratories.(Product Briefs)(Prostate Px+ from Aureon Laboratories)(Brief article)
July 10, 2008... Aureon Laboratories (Yonkers, New York) has introduced Prostate Px+, a test that predicts prostate cancer progression and disease recurrence at the time of diagnosis. "Prostate Px+ is the first prognostic test to provide this critical...

Clarient.(Product Briefs)
July 10, 2008... Clarient (Aliso Viejo, California) reported its new offering, KRAS, which has been validated as a laboratory-developed test to be used as a predictive molecular biomarker for patients with colorectal cancer (CRC). In colorectal cancers,...

Neoprobe.(Product Briefs)(Neoprobe corp. introduces Neoprobe GDS )
July 10, 2008... Neoprobe (Dublin, Ohio) said it has introduced an enhanced gamma detection control unit, the Neoprobe GDS (Model 2300), in connection with the company's marketing partner, Ethicon Endo-Surgery. The Neoprobe GDS control unit contains internal...

Del Global Technologies'.(People in Places)(Del Global Technologies appointed Dennis Runyan )(Brief article)
July 10, 2008... Dennis Runyan was named VP of sales for Del Global Technologies' (Franklin Park, Illinois) digital radiographic solutions in the Americas. Runyan joins Del Global from Anexa, a subsidiary of Analogic, where he served as VP of sales and service....

Misonix.(People in Places)
July 10, 2008... Neil Blewitt has been named senior managing director of Misonix's (Farmingdale, New York) Labcaire subsidiary. Blewitt joins Misonix with more than 20 years of business unit and general manager experience, all in international manufacturing...

Pulmonologists use GPS-like device to see deep lung areas.
July 17, 2008... Pulmonologists at Presbyterian Hospital (Dallas) have begun using a new type of bronchoscopy that uses GPS-like technology to generate 3-D images of the far reaches of complex lung structures. This electromagnetic navigational bronchoscopy is...

NanobioSensors will provide real-time patient monitoring.
July 17, 2008... Managing patients in trauma units or those with chronic diseases typically amounts to taking periodic snapshots of blood and urine proteins. But changes can occur rapidly and physicians would be far better equipped to effectively personalize...

LabCorp has promising results with an ovarian cancer assay.
July 17, 2008... Every year, nearly 21,650 women are diagnosed with ovarian cancer. Of that number, nearly 21,650 women die from the disease. Ovarian cancer is said to be three times more lethal than breast cancer. But if the disease is detected at an early...

Gen-Probe drops Innogenetics bid after higher Solvay offer.(Deals roundup)
July 17, 2008... Gen-Probe (San Diego) reported that the company does not intend to increase the value of its conditional tender offer to acquire Innogenetics (Ghent, Belgium), a molecular diagnostics company, in the wake of a higher offer by a rival suitor....

TheraGenetics.(Deals roundup)(Brief article)
July 17, 2008... TheraGenetics (London), a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system (CNS) disorders, said it has...

Luminex.(Deals roundup)(Brief article)
July 17, 2008... Luminex (Austin, Texas) and ViroNovative (Rotterdam, the Netherlands) reported that the companies have signed a licensing agreement that gives Luminex worldwide rights to use ViroNovative's human metapneumovirus (hMPV) intellectual property in...

Agendia BV.(Deals roundup)
July 17, 2008... Agendia BV (Amsterdam, the Netherlands) said it has agreed to give Ferrer inCode (Barcelona, Spain) exclusive rights to sell two of its signature cancer diagnostics services: MammaPrint, a prognostic test that uses a 70-gene signature to...

DNA Repair Company.(Deals roundup)
July 17, 2008... The DNA Repair Company (DNAR; Boston), an emerging company focused on personalized approaches to cancer treatment, said it has licensed the exclusive rights in North America for the use of a diagnostic test that strongly predicts how women with...

Contingency fees seen as big problem with hired auditors.(Washington roundup)
July 17, 2008... Keeping a lid on the Medicare budget by cutting down on fraud and improper payments is an ongoing job at the Centers for Medicare & Medicaid Services, which announced last week that a pilot program that ran from 2005 to this past March saved...

CT energy may interact with devices.(Washington roundup)
July 17, 2008... FDA published a public safety statement yesterday that some pacemakers, defibrillators, neurostimulators and infusion pumps may present a hazard when exposed to X-rays during computed tomography (CT) imaging sessions in a small percentage of...

GHTF publishes diagnostics guidance.(Washington roundup)(Brief article)
July 17, 2008... The Global Harmonization Task Force (GHTF) has published a guidance for classification of in-vitro diagnostics (IVD) for those who want to market internationally. The guidance describes four categories of classification, from A to D, and...

BD Diagnostics gets CE mark for its GeneOhm Cdiff assay.(International report)
July 17, 2008... BD Diagnostics (San Diego), a unit of BD (Becton, Dickinson and Co.; Franklin Lakes, New Jersey) reported receiving the CE mark for the BD GeneOhm Cdiff molecular assay for the rapid diagnosis of patients with Clostridium difficile infection...

Russian distributor for Spectral.(International report)
July 17, 2008... Spectral Diagnostics (Toronto) said it has entered into an exclusive distribution agreement in Russia with BB Medical to distribute Spectral's Endotoxin Activity Assay (EAA), the only FDA-cleared assay for the measurement of endotoxin. BB...

NIOX Mino approved in China.(International report)
July 17, 2008... Aerocrine (Stockholm, Sweden) said its hand-held airway inflammation monitor, NIOX Mino, has been registered for marketing and sale in China. The company's method of measuring airway inflammation, using exhaled nitric oxide (NO) tests, has...

Adnavance adds C$1.8m to 'B' round for M-DNA milestone.(Financings roundup)
July 17, 2008... Adnavance (Vancouver, British Columbia), a developer of direct detection molecular diagnostic tests, said it will receive an additional C$1.8 million as part of its Series B financing, because it has met a milestone in progressing its metalized...

Vantage Oncology.(Financings roundup)(Brief article)
July 17, 2008... Vantage Oncology (Manhattan Beach, California) reported that it has closed on a $100 million term loan facility, with Ares Capital acting as the lead arranger. The facility is structured as a delayed-draw term loan to support future...

Bio-Reference Laboratories.(Financings roundup)
July 17, 2008... Bio-Reference Laboratories (BRL; Elmwood Park, New Jersey) reported that its board has approved a stock repurchase program authorizing the repurchase of up to 1 million shares of its common stock on the over-the-counter market at prevailing...

Commonwealth Biotechnologies.(Financings roundup)(Brief article)
July 17, 2008... Commonwealth Biotechnologies (CBI; Richmond, Virginia) said it has sold 463,426 shares of its common stock subject to a $1 million put right to Venturepharm Laboratories (VPL; Beijing, China) for $2.15 a share, a 56% premium to the June 30...

Hoana Medical reports new deals for its LifeBed patient monitor.(Grants/contracts)
July 17, 2008... Hoana Medical (Honolulu) reported new partnerships with a large healthcare system in Pennsylvania, the Veterans Administration (VA) with VA hospitals in Florida and Nebraska, and the U.S. Army to improve patient safety in acute-care hospitals....

Merge Healthcare regains Nasdaq compliance.(Med-tech news and notes)
July 17, 2008... Merge Healthcare (Milwaukee) it has received notification from the Nasdaq stock market that the company had regained compliance with Nasdaq marketplace rule 4450(a)(5) and that Nasdaq now considers the matter closed. The company was...

Fonar receives Nasdaq compliance letter.(Med-tech news and notes)
July 17, 2008... Fonar (Melville, New York) said that on July 8 it received a letter from Nasdaq indicating that the company is not in compliance with marketplace rules 4350(e) and 4350(g) due to the fact that it has not yet solicited proxies and held its...

Echo Therapeutics.(Product Briefs)(Brief article)
July 17, 2008... Echo Therapeutics (Franklin, Massachusetts) reported publication of results from three pilot clinical studies of its Symphony Transdermal Continuous Glucose Monitoring (tCGM) system in the Journal of Diabetes Science and Technology. The article...

Lumedx.(Product Briefs)(Brief article)
July 17, 2008... Lumedx (Oakland, California) reported the introduction of CardioPACS 5.0, the latest version of its cardiology PACS software. Multi-modality, web-enabled and vendorneutral, CardioPACS 5.0 is a next-generation PACS solution. With CardioPACS 5.0,...

Masimo.(Product Briefs)(Brief article)
July 17, 2008... Masimo (Irvine, California) said that a new clinical study, published in the June issue of the British Journal of Anaesthesia, concluded that under the study protocol Masimo's PVI measurement "can predict fluid responsiveness in...

NewCardio.(Product Briefs)
July 17, 2008... NewCardio (Santa Clara, California) reported the results of its second external validation study of QTinno (the NCE2 Study). The study was led by an independent industry leading cardiac safety expert with extensive experience in pharmaceutical...

Rosetta Genomics.(Product Briefs)
July 17, 2008... Rosetta Genomics (Jersey City, New Jersey) said that the results of a study conducted by its scientists and collaborators and describing the use of microRNAs in accurately differentiating primary from metastatic tumors of the brain, have been...

Bioheart.(People in Places)(Brief article)
July 17, 2008... Bioheart (Sunrise, Florida) said that Doug Owens, director, clinical affairs, will assume responsibility for Bioheart's regulatory and clinical strategy for its investigational MyoCell therapy clinical trials. Owens has previously managed the...